scispace - formally typeset
S

Salvatore De Fazio

Researcher at Magna Græcia University

Publications -  19
Citations -  560

Salvatore De Fazio is an academic researcher from Magna Græcia University. The author has contributed to research in topics: Epilepsy & Levetiracetam. The author has an hindex of 13, co-authored 18 publications receiving 515 citations.

Papers
More filters
Journal ArticleDOI

Comparison of the antiepileptogenic effects of an early long-term treatment with ethosuximide or levetiracetam in a genetic animal model of absence epilepsy.

TL;DR: The aim of the experiments was to determine, in the WAG/Rij model of absence epilepsy, if early long‐term treatment with some established antiabsence drugs might prevent the development of seizures, and whether such an effect could be sustained.
Journal ArticleDOI

Adverse effects of atypical antipsychotics in the elderly: a review.

TL;DR: T careful review of the literature suggests that the available evidence does not support any causal relationship between use of risperidone or olanzapine and cardiovascular events, and this article focuses on some of the main adverse effects commonly reported during administration of atypical antipsychotics to elderly patients.
Journal ArticleDOI

Effects of early long‐term treatment with antiepileptic drugs on development of seizures and depressive‐like behavior in a rat genetic absence epilepsy model

TL;DR: The effects of long‐term treatment with several AEDs on absence seizure development and onset of depressive‐like behavior in WAG/Rij rats at different ages are examined, using a forced swimming test (FST).
Journal ArticleDOI

Patterns of prescription of antiepileptic drugs in patients with refractory epilepsy at tertiary referral centres in Italy.

TL;DR: Prescription patterns were consistent with current evidence about the spectrum of efficacy of individual AEDs in different epilepsy syndromes, and the high prevalence of polytherapy, including combinations of three or more Aeds, is a cause for concern.
Journal ArticleDOI

The safety of clozapine in the elderly

TL;DR: Clozapine treatment in the elderly requires a careful geriatric assessment and its use is strongly limited by the possibility of onset of severe adverse effects such as potentially fatal agranulocytosis, myocarditis and others such as seizures, weight gain and metabolic adverse effects.